UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Giant cell arteritis: strategies in diagnosis and treatment

Current opinion in rheumatology, 2004-01, Vol.16 (1), p.25-30

2004

Volltextzugriff (PDF)

Stereological study of neovascularization in temporal arteritis

Journal of rheumatology, 2006-10, Vol.33 (10), p.2020

2006

Volltextzugriff (PDF)

Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis

Journal of rheumatology, 2003-07, Vol.30 (7), p.1456

2003

Volltextzugriff (PDF)

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

Annals of the rheumatic diseases, 2015-10, Vol.74 (10), p.1799-1807

2015

Volltextzugriff (PDF)

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

Annals of the rheumatic diseases, 2012-04, Vol.71 (4), p.484-492

2012

Volltextzugriff (PDF)

2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative

Arthritis & rheumatology (Hoboken, N.J.), 2015-10, Vol.67 (10), p.2569-2580

2015

Volltextzugriff (PDF)

Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus

Annals of the rheumatic diseases, 2011-03, Vol.70 (3), p.447-453

2011

Volltextzugriff (PDF)

Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis

Annals of the rheumatic diseases, 2006-04, Vol.65 (4), p.529-532

2006

Volltextzugriff (PDF)

Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis

Annals of the rheumatic diseases, 2003-07, Vol.62 (7), p.617-623

2003

Volltextzugriff (PDF)

Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis

Scandinavian journal of rheumatology, 2009-01, Vol.38 (2), p.144-148

2009

Volltextzugriff (PDF)

Difficulties in the development of histological scoring of the inflamed temporal arteries in giant cell arteritis

Rheumatology (Oxford, England), 2005-12, Vol.44 (12), p.1579-1580

2005

Volltextzugriff (PDF)

Search for varicella zoster virus in giant cell arteritis

Annals of neurology, 1998-09, Vol.44 (3), p.413-414

1998

Volltextzugriff (PDF)

Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]

Arthritis research & therapy, 2004-09, Vol.6 (5), Article R457

2004

Volltextzugriff (PDF)

Cell-type-specific expression of p53 and p21 in giant cell arteritis

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2005-09, Vol.113 (9), p.594-599

2005

Volltextzugriff (PDF)

A Western blot and molecular genetic investigation of the estrogen receptor beta in giant cell arteritis

Clinical and experimental rheumatology, 2006-03, Vol.24 (2 Suppl 41), p.S17

2006

Volltextzugriff (PDF)

Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1

Arthritis research & therapy, 2003-01, Vol.5 (4), p.R202-R209, Article R202

2003

Volltextzugriff (PDF)

2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative

Arthritis and rheumatism, 2012-04, Vol.64 (4), p.943-954

2012

Volltextzugriff (PDF)

Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]

Arthritis research & therapy, 2004, Vol.6 (5), p.R457-R468

2004

Volltextzugriff (PDF)

Chapter 9 Large and Medium Vessel Vasculitis: Mechanisms

Handbook of Systemic Autoimmune Diseases, 2007, Vol.7, p.159-173

2007

Volltextzugriff (PDF)

Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy

BMJ (Online), 1989-08, Vol.299 (6698), p.549

1989

Volltextzugriff (PDF)

Giant cell arteritis

Current opinion in rheumatology, 1992-02, Vol.4 (1), p.23-30

1992

Volltextzugriff (PDF)

Giant-cell arteritis: A clinical and morphological study

Nordborg, Elisabeth

1991

Volltextzugriff (PDF)

von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis

Annals of the rheumatic diseases, 1991-05, Vol.50 (5), p.316-320 ; 0

1991

Volltextzugriff (PDF)

Giant cell arteritis. Epidemiology and treatment

Drugs & aging, 1994-02, Vol.4 (2), p.135-144

1994

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(23)
Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Female
(16)
Rheumatology
(16)
Aged
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Middle Aged
(12)
Aged, 80 And Over
(10)
Male
(10)
Medical And Health Sciences
(10)
Medicin Och Hälsovetenskap
(10)
Diseases Of The Osteoarticular System
(9)
Temporal Arteritis
(7)
Giant Cell Arteritis
(6)
Giant Cell Arteritis - Pathology
(6)
Rheumatoid Arthritis
(6)
Arthritis
(5)
Glucocorticoids - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Giant cell arteritis: strategies in diagnosis and treatment

Patient-reported outcomes in polymyalgia rheumatica

Stereological study of neovascularization in temporal arteritis

Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative

2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative

Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus

Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis

Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis

Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis

Difficulties in the development of histological scoring of the inflamed temporal arteries in giant cell arteritis

Search for varicella zoster virus in giant cell arteritis

Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]

Cell-type-specific expression of p53 and p21 in giant cell arteritis

A Western blot and molecular genetic investigation of the estrogen receptor beta in giant cell arteritis

Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1

2012 Provisional classification criteria for polymyalgia rheumatica: A European League Against Rheumatism/American College of Rheumatology collaborative initiative

Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]

Chapter 9 Large and Medium Vessel Vasculitis: Mechanisms

Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy

Giant cell arteritis

Giant-cell arteritis: A clinical and morphological study

von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis

Giant cell arteritis. Epidemiology and treatment

Suchergebnisse filtern